Welcome to our dedicated page for SCHWAB CHARLES SEC filings (Ticker: SCHW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SCHWAB CHARLES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SCHWAB CHARLES's regulatory disclosures and financial reporting.
Brown Marianne Catherine reported acquisition or exercise transactions in this Form 4 filing.
Charles Schwab director Marianne Catherine Brown received 434 Restricted Stock Units (RSUs) as a grant under the company's Directors' Deferred Compensation Plan II. Each RSU represents one share of common stock and was taken in lieu of cash director fees.
The RSUs are held in a rabbi trust for her benefit and will be distributed when she leaves the Board of Directors, deferring receipt of the shares until that time. Following this award and prior dividend reinvestments, she now holds a total of 7,823.67 RSUs.
Director Charles A. Ruffel of Schwab Charles Corp received a grant of 1,286 nonqualified stock options on April 1, 2026. Each option allows him to buy one share of common stock at an exercise price of $92.36 per share.
The options were granted under the Directors' Deferred Compensation Plan II, vested immediately, and were received in lieu of cash director fees. This is a compensation-related award rather than an open-market stock purchase or sale.
HERRINGER FRANK C reported acquisition or exercise transactions in this Form 4 filing.
Schwab Charles Corp director Frank C. Herringer reported receiving 474 restricted stock units (RSUs) on April 1, 2026. Each RSU represents a right to receive one share of Schwab common stock and was granted in lieu of cash director fees under the Directors' Deferred Compensation Plan II.
The RSUs are held in a rabbi trust for his benefit and will be distributed when he leaves the Board of Directors. Following this award and prior accruals, including 500.51 RSUs from dividend reinvestment, he holds a total of 151,757.24 RSUs directly.
Charles Schwab Corporation director Stephen A. Ellis received a grant of 393 restricted stock units (RSUs) on company stock as a compensation award. Each RSU represents the right to receive one share of common stock. The RSUs were issued under the Directors' Deferred Compensation Plan II in lieu of cash director fees and are held in a rabbi trust for his benefit, to be distributed when he leaves the Board of Directors. Following this award, Ellis holds a total of 12,851.98 RSUs, which includes 41.22 RSUs acquired through dividend reinvestment.
The Charles Schwab Corporation is soliciting proxies for its 2026 Annual Meeting of Stockholders to be held virtually on May 21, 2026. Stockholders of record as of March 23, 2026 may vote. The meeting agenda includes election of four directors, ratification of Deloitte as independent auditors, advisory approval of named executive officer compensation, and a proposal to declassify the board over a three-year phase-out.
Highlights disclosed include $11.9 trillion in client assets as of December 31, 2025, 38.5 million active brokerage accounts, and executive compensation actions: the Compensation Committee certified annual cash incentive funding at 116.51% based on adjusted diluted EPS of $4.87 versus a target of $4.18. The board reduced its authorized size from 14 to 13 effective at the meeting and approved modest increases to non-employee director compensation effective January 1, 2026 (cash retainer to $110,000 and annual equity grant to $240,000).
The Vanguard Group filed Amendment No. 10 to a Schedule 13G/A for Charles Schwab Corp. reporting 0 shares beneficially owned, representing 0% of the common stock. The filing notes an internal realignment effective January 12, 2026 that disaggregated certain subsidiaries' holdings for separate reporting. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Charles Schwab director Stephen A. Ellis exercised stock options to acquire additional common shares. On March 24, 2026 he exercised options on 9,765 shares of Charles Schwab common stock at exercise prices of $28.38 and $28.96 per share, fully converting these option grants into shares.
Following the transactions, Ellis held 6,660 shares of common stock directly. A footnote explains that shares received upon exercise were contributed to a revocable trust, which held 97,327.5296 Charles Schwab common shares indirectly on his behalf. The filing shows only option exercises and related transfers, with no open-market share sales.
Schwab Chief Risk Officer Nigel J. Murtagh reported selling 7,203 shares of Charles Schwab common stock in open-market transactions. The sales occurred on March 3, 2026 in two trades: 4,463 shares at a weighted average price of $94.4274 and 2,740 shares at $94.8993.
The filing notes these sales were made under a Rule 10b5-1 trading plan adopted on November 25, 2025. After the transactions, Murtagh directly holds 57,972.4846 shares of Schwab common stock and indirectly holds 2,484 shares through an employee stock purchase plan, based on a plan statement as of January 30, 2026.
Charles Schwab executive Jonathan M. Craig reported preset insider sales of company stock. A trust associated with him sold a total of 14,481 shares of Charles Schwab common stock in two open-market transactions on March 3, 2026, at weighted average prices of $94.4218 and $94.8943. These sales were made under a Rule 10b5-1 trading plan adopted on November 11, 2025, and left the trust with no remaining Schwab shares.
Charles Schwab Corporation executive Dennis Howard, MD and Chief Technology, Operations & Data Officer, reported selling a total of 10,108 shares of Schwab common stock in open-market transactions on March 3, 2026. The sales were executed at weighted average prices of $94.4316 and $94.8778 per share.
The transactions were carried out under a pre-arranged Rule 10b5-l trading plan adopted on November 25, 2025. Following these sales, Howard directly owns 10,470 shares of Schwab common stock.